SARA GASPARD: Open Payments
NPI 1558913806 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 13 payments from 8 companies in 2025. Trend: 2023 $253 · 2024 $282 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 3 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| TOLMAR, INC. | 2 | $45 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| ABBVIE INC. | 1 | $41 |
| Janssen Biotech, Inc. | 1 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| UROGEN PHARMA, INC. | 1 | $18 |
Products named: XYOSTED, GEMTESA, AZMIRO, BOTOX, ERLEADA, JOURNAVX, JATENZO, ELIGARD.
Industry payments across LA — which companies pay providers there.
